Silent Heart Attack Raises Cerebral Infarction Risk
By HospiMedica International staff writers Posted on 06 Jun 2019 |
A new study reveals that asymptomatic (silent) heart attacks are associated with double the risk of cardiac embolism and stroke of undetermined cause.
Researchers at Weill Cornell Medical College (New York, NY, USA), the Icelandic Heart Association (IHA; Kopavogur, Iceland), and other institutions conducted a cross-sectional study that included 925 community-dwelling Icelandic individuals (51.9% women, mean age 75.9 years) who underwent both brain magnetic resonance imaging (MRI) and late gadolinium enhanced cardiac MRI to determine whether unrecognized mitral infarction (MI) is associated with cerebral infarction. The main outcomes and measures were unrecognized MI, defined as cardiac MRI evidence of MI without a history of clinical evidence.
The results revealed that 23.9% of participants had cardiac MRI evidence of a heart attack. Of these, 67 experienced MI with symptoms, while 153 had silent heart attack. Overall, 33% had brain MRI evidence of a stroke, and 10% had a stroke of undetermined cause. The researchers calculated that people with symptomatic MI were twice as likely to have a stroke, while those with silent heart attack were 1.5 times as likely to have a stroke. Adjusted for demographics and vascular risk factors, unrecognized MI was also associated with embolic infarcts of undetermined source. The study was published on May 20, 2019, in JAMA Neurology.
“Silent heart attack may be a risk factor for stroke, and may explain some proportion of stroke of undetermined cause; the clot formation that occurs with symptomatic heart attack may also occur with silent heart attack,” said lead study author neurologist Alexander Merkler, MD, of Weill Cornell Medical College. “If further studies confirm these results, doctors may more readily use cardiac MRI in patients with stroke of undetermined cause to see whether there is evidence of silent heart attack. They may also want to compare the effectiveness of anticoagulants to antiplatelet medications such as aspirin, which prevent platelets from clumping together.”
More than 700,000 people a year in the United States alone are diagnosed with a stroke, but in 20-25% of these patients, the cause of stroke cannot be determined. One possible explanation for these strokes is that a distant blood clot travels to the brain following a heart attack. About 50% of all heart attack patients do not experience any symptoms.
Related Links:
Weill Cornell Medical College
Icelandic Heart Association
Researchers at Weill Cornell Medical College (New York, NY, USA), the Icelandic Heart Association (IHA; Kopavogur, Iceland), and other institutions conducted a cross-sectional study that included 925 community-dwelling Icelandic individuals (51.9% women, mean age 75.9 years) who underwent both brain magnetic resonance imaging (MRI) and late gadolinium enhanced cardiac MRI to determine whether unrecognized mitral infarction (MI) is associated with cerebral infarction. The main outcomes and measures were unrecognized MI, defined as cardiac MRI evidence of MI without a history of clinical evidence.
The results revealed that 23.9% of participants had cardiac MRI evidence of a heart attack. Of these, 67 experienced MI with symptoms, while 153 had silent heart attack. Overall, 33% had brain MRI evidence of a stroke, and 10% had a stroke of undetermined cause. The researchers calculated that people with symptomatic MI were twice as likely to have a stroke, while those with silent heart attack were 1.5 times as likely to have a stroke. Adjusted for demographics and vascular risk factors, unrecognized MI was also associated with embolic infarcts of undetermined source. The study was published on May 20, 2019, in JAMA Neurology.
“Silent heart attack may be a risk factor for stroke, and may explain some proportion of stroke of undetermined cause; the clot formation that occurs with symptomatic heart attack may also occur with silent heart attack,” said lead study author neurologist Alexander Merkler, MD, of Weill Cornell Medical College. “If further studies confirm these results, doctors may more readily use cardiac MRI in patients with stroke of undetermined cause to see whether there is evidence of silent heart attack. They may also want to compare the effectiveness of anticoagulants to antiplatelet medications such as aspirin, which prevent platelets from clumping together.”
More than 700,000 people a year in the United States alone are diagnosed with a stroke, but in 20-25% of these patients, the cause of stroke cannot be determined. One possible explanation for these strokes is that a distant blood clot travels to the brain following a heart attack. About 50% of all heart attack patients do not experience any symptoms.
Related Links:
Weill Cornell Medical College
Icelandic Heart Association
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergency Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure